High Vision Medical now has a wide range of ophthalmic equipment layout, across the four major sectors of ophthalmic diagnostic equipment, ophthalmic surgery equipment, ophthalmic surgical equipment, and ophthalmic consumables. Examination, treatment and correction of seven ophthalmology subspecialty diseases, optometry, ocular surface and children’s ophthalmology. Listed on the Hong Kong Stock Exchange today. For this listing, the issue price of High Vision Medical is determined to be HK$51.40 per share. Based on this calculation, Gaoshi Medical is expected to raise approximately HK$672 million. The prospectus shows that the company expects a net fundraising of approximately HK$283 million and a market value of approximately HK$7.604 billion.
This article is transferred from: https://www.itjuzi.com/investevent/13712099
This site is only for collection, and the copyright belongs to the original author.